At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Double-Blind, Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of LT3001 Drug Product and Drug-Drug Interaction in Healthy Adult Subjects
In Brief
A Phase 1 clinical trial evaluating LT3001 drug product, Placebo, and 4 other interventions for Acute Ischemic Stroke. Completed, enrolled 65 participants across 1 site.
Detailed Summary
This Phase 1 study is planned to establish the clinical safety and pharmacokinetics profile of multiple dose of LT3001 drug product and to investigate drug interactions of LT3001 with potential concomitant medications in healthy subjects.
Study Details
Timeline
Interventions
Multiple doses of LT3001 drug product administered by intravenous infusion
Multiple doses of Placebo administered by intravenous infusion
Loading and maintenance doses of Aspirin administered by oral
Loading and maintenance doses of Clopidogrel administered by oral
Multiple doses of Apixaban administered by oral
Multiple doses of Dabigatran administered by oral